Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Roden

Showing results (201-210 of 237) with videos related to

Pageof 24
Sort By:
Journal of the American College of Cardiology|December 1, 1983
Electrophysiologic actions of high plasma concentrations of propranolol in human subjectsH J Duff, D M Roden, L Brorson, et al.
Clinical Pharmacology and Therapeutics|January 21, 2011
The emerging role of electronic medical records in pharmacogenomicsR A Wilke, H Xu, J C Denny, et al.
The Journal of Clinical Investigation|March 1, 1990
Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockadeK T Murray, C Reilly, R P Koshakji, et al.
Journal of Cardiovascular Electrophysiology|September 1, 1994
Effects of procainamide and lidocaine on defibrillation energy requirements in patients receiving implantable cardioverter defibrillator devicesD S Echt, S T Gremillion, J T Lee, et al.
The American Journal of Cardiology|December 1, 1981
Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainideH J Duff, D M Roden, R J Maffucci, et al.
The Pharmacogenomics Journal|May 16, 2012
Novel rare variants in congenital cardiac arrhythmia genes are frequent in drug-induced torsades de pointesA H Ramirez, C M Shaffer, J T Delaney, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
A common polymorphism associated with antibiotic-induced cardiac arrhythmiaF Sesti, G W Abbott, J Wei, et al.
Clinical Pharmacology and Therapeutics|August 1, 1986
Encainide disposition in patients with chronic cirrhosisR H Bergstrand, T Wang, D M Roden, et al.
Clinical Pharmacology and Therapeutics|May 24, 2013
Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 updateS A Scott, K Sangkuhl, C M Stein, et al.
The American Journal of Cardiology|January 1, 1989
Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study)H L Greene, D W Richardson, A H Barker, et al.
Pageof 24

Showing results (201-210 of 237) with videos related to

Sort By:
Pageof 24
Journal of the American College of Cardiology|December 1, 1983
Electrophysiologic actions of high plasma concentrations of propranolol in human subjectsH J Duff, D M Roden, L Brorson, et al.
Clinical Pharmacology and Therapeutics|January 21, 2011
The emerging role of electronic medical records in pharmacogenomicsR A Wilke, H Xu, J C Denny, et al.
The Journal of Clinical Investigation|March 1, 1990
Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockadeK T Murray, C Reilly, R P Koshakji, et al.
Journal of Cardiovascular Electrophysiology|September 1, 1994
Effects of procainamide and lidocaine on defibrillation energy requirements in patients receiving implantable cardioverter defibrillator devicesD S Echt, S T Gremillion, J T Lee, et al.
The American Journal of Cardiology|December 1, 1981
Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainideH J Duff, D M Roden, R J Maffucci, et al.
The Pharmacogenomics Journal|May 16, 2012
Novel rare variants in congenital cardiac arrhythmia genes are frequent in drug-induced torsades de pointesA H Ramirez, C M Shaffer, J T Delaney, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
A common polymorphism associated with antibiotic-induced cardiac arrhythmiaF Sesti, G W Abbott, J Wei, et al.
Clinical Pharmacology and Therapeutics|August 1, 1986
Encainide disposition in patients with chronic cirrhosisR H Bergstrand, T Wang, D M Roden, et al.
Clinical Pharmacology and Therapeutics|May 24, 2013
Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 updateS A Scott, K Sangkuhl, C M Stein, et al.
The American Journal of Cardiology|January 1, 1989
Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study)H L Greene, D W Richardson, A H Barker, et al.
Pageof 24